September 9, 2024-September 11, 2024 Register Now for C-Path’s Premier Global Impact Conference We are thrilled to invite you to the inaugural Critical Path Institute Global Impact Conference taking place this September...
August 17, 2022 View Now | Addressing the Gaps in Clinical Trial Readiness for FSHD Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common myopathies affecting anywhere between 1:8,000 to 1:20,000
March 28, 2024 C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...
